137 related articles for article (PubMed ID: 20222907)
1. The predictors of complications in patients with drug-induced liver injury caused by antimicrobial agents.
Treeprasertsuk S; Huntrakul J; Ridtitid W; Kullavanijaya P; Björnsson ES
Aliment Pharmacol Ther; 2010 Jun; 31(11):1200-7. PubMed ID: 20222907
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment.
Cano-Paniagua A; Amariles P; Angulo N; Restrepo-Garay M
Ann Hepatol; 2019; 18(3):501-507. PubMed ID: 31053545
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced liver injury: A 2-year retrospective study of 1169 hospitalized patients in a single medical center.
Woo HJ; Kim HY; Choi ES; Cho YH; Kim Y; Lee JH; Jang E
Phytomedicine; 2015 Dec; 22(13):1201-5. PubMed ID: 26598920
[TBL] [Abstract][Full Text] [Related]
4. Montelukast induced acute hepatocellular liver injury.
Harugeri A; Parthasarathi G; Sharma J; D'Souza GA; Ramesh M
J Postgrad Med; 2009; 55(2):141-2. PubMed ID: 19550064
[TBL] [Abstract][Full Text] [Related]
5. Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality.
Rathi C; Pipaliya N; Patel R; Ingle M; Phadke A; Sawant P
Ann Hepatol; 2017; 16(3):442-450. PubMed ID: 28425415
[TBL] [Abstract][Full Text] [Related]
6. [RUCAM scale-based diagnosis, clinical features and prognosis of 140 cases of drug-induced liver injury].
Hao K; Yu Y; He C; Wang M; Wang S; Li X
Zhonghua Gan Zang Bing Za Zhi; 2014 Dec; 22(12):938-41. PubMed ID: 25654289
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.
García-Cortés M; Lucena MI; Pachkoria K; Borraz Y; Hidalgo R; Andrade RJ;
Aliment Pharmacol Ther; 2008 May; 27(9):780-9. PubMed ID: 18284654
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced liver injury in the Australian setting.
Sistanizad M; Peterson GM
J Clin Pharm Ther; 2013 Apr; 38(2):115-20. PubMed ID: 23350857
[TBL] [Abstract][Full Text] [Related]
9. An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data.
Cheetham TC; Lee J; Hunt CM; Niu F; Reisinger S; Murray R; Powell G; Papay J
Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):601-8. PubMed ID: 24920207
[TBL] [Abstract][Full Text] [Related]
10. Causality assessment of herb-induced liver injury using multidisciplinary approach and Roussel Uclaf Causality Assessment Method (RUCAM).
Nin Chau T; Cheung WI; Ngan T; Lin J; Lee KW; Tat Poon W; Leung VK; Mak T; Tse ML;
Clin Toxicol (Phila); 2011 Jan; 49(1):34-9. PubMed ID: 21114414
[TBL] [Abstract][Full Text] [Related]
11. Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?
Vuppalanchi R; Liangpunsakul S; Chalasani N
Am J Gastroenterol; 2007 Mar; 102(3):558-62; quiz 693. PubMed ID: 17156142
[TBL] [Abstract][Full Text] [Related]
12. Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury.
Benesic A; Leitl A; Gerbes AL
Gut; 2016 Sep; 65(9):1555-63. PubMed ID: 26045135
[TBL] [Abstract][Full Text] [Related]
13. Acute drug-induced hepatitis caused by albendazole.
Choi GY; Yang HW; Cho SH; Kang DW; Go H; Lee WC; Lee YJ; Jung SH; Kim AN; Cha SW
J Korean Med Sci; 2008 Oct; 23(5):903-5. PubMed ID: 18955802
[TBL] [Abstract][Full Text] [Related]
14. Clinical Spectrum and Outcome of Pediatric Drug Induced Liver Injury.
Kumar A; Sood V; Khanna R; Verma SK; Mehra N; Rawat D; Alam S
Indian J Pediatr; 2018 Aug; 85(8):676-678. PubMed ID: 29247427
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and prognostic markers in disulfiram-induced liver injury.
Björnsson E; Nordlinder H; Olsson R
J Hepatol; 2006 Apr; 44(4):791-7. PubMed ID: 16487618
[TBL] [Abstract][Full Text] [Related]
16. Hepatotoxicity of antibiotics: a review and update for the clinician.
Stine JG; Lewis JH
Clin Liver Dis; 2013 Nov; 17(4):609-42, ix. PubMed ID: 24099021
[TBL] [Abstract][Full Text] [Related]
17. Clinical course and outcomes of drug-induced liver injury: nimesulide as the first implicated medication.
Licata A; Calvaruso V; Cappello M; Craxì A; Almasio PL
Dig Liver Dis; 2010 Feb; 42(2):143-8. PubMed ID: 19625223
[TBL] [Abstract][Full Text] [Related]
18. Outcome and prognostic markers in severe drug-induced liver disease.
Björnsson E; Olsson R
Hepatology; 2005 Aug; 42(2):481-9. PubMed ID: 16025496
[TBL] [Abstract][Full Text] [Related]
19. 62-year-old man with painless jaundice and hyponatremia.
Cangemi DJ; Donovan ST; Johnson MM
Mayo Clin Proc; 2013 Jun; 88(6):e49-53. PubMed ID: 23726406
[No Abstract] [Full Text] [Related]
20. Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury.
Rochon J; Protiva P; Seeff LB; Fontana RJ; Liangpunsakul S; Watkins PB; Davern T; McHutchison JG;
Hepatology; 2008 Oct; 48(4):1175-83. PubMed ID: 18798340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
